Trial intelligence / Profile preview

Cisplatin and Etoposide for CNS Germ Cell Tumors

NCT00002472Phase 2Completed

Sponsor
Mayo Clinic
Start
Mar 1991
Primary completion
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cisplatin, etoposide in central nervous system germ cell tumor, sponsored by Mayo Clinic. Started Mar 1991; status: completed.

02

Drugs

cisplatinetoposide
03

Conditions

central nervous system germ cell tumor

Beyond the preview

Go deeper on NCT00002472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call